<DOC>
	<DOCNO>NCT01952288</DOCNO>
	<brief_summary>Study simvastatin vs. pravastatin Iraq/Afghanistan Veterans multiple blast exposure mTBI . The study measure substances cerebrospinal fluid ( CSF ) relate dementing disorder .</brief_summary>
	<brief_title>Simvastatin mTBI-II</brief_title>
	<detailed_description>Many Iraq Afghanistan Veterans experience repetitive blast exposure mild traumatic brain injury ( mTBI ) persistent cognitive , emotional , neurological postconcussive symptom . There urgent need develop effective treatment reduce intensity Veterans ' current symptom well potential long-term risk develop neurodegenerative dementing disorder related repetitive mTBI : chronic traumatic encephalopathy ( CTE ) Alzheimer 's disease ( AD ) . Converging evidence suggest statin may possess neuroprotective effect pathologic process related tau protein metabolism appear common feature CTE , AD , neurodegenerative sequela repetitive mTBI . The investigator propose 12-month , double-blind , randomize , active-drug-controlled trial establish proof-of-concept use simvastatin ( 40 mg/d ) decrease CSF biomarkers neurodegeneration increase CSF neurotrophins 120 Iraq Afghanistan Veterans repetitive blast trauma mTBI .</detailed_description>
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Pravastatin</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Males female age 2150 year . Documented hazardous duty Iraq Afghanistan U.S. Armed Forces . Exposure one blast trauma event result mTBI accord American Congress Rehabilitation Medicine ( ACRM ) criterion . More 6 month since last blast trauma exposure Ability complete psychometric clinical assessment English ( i.e. , adequate English language skill , vision hearing ) . elevate cholesterol level , i.e . total cholesterol &gt; 200 and/or LDL &gt; 130 . This would generally prompt initiation lipidlowering agent standard care general medical community . No use statins previous year recent ( past 4 week ) use lipidlowering drug ( e.g. , fibrates , niacin &gt; 500mg/d , high dose omega3 fatty acid ) precede randomization . No clinically significant laboratory abnormality ( electrolyte , glucose , carbon dioxide , blood urea nitrogen ( BUN ) , creatinine , vitamin B12 , folate , albumin , thyroid stimulate hormone ) . Platelet count &gt; 100,000/mm2 . Body Mass Index ( BMI ) 18 36 inclusive History head trauma loss consciousness ( LOC ) &gt; 30 minute , penetrate head wound , moderate severe memory cognitive impairment . Neurological disorder : multiple sclerosis , epilepsy , stroke , Parkinson 's disease ( PD ) , degenerative Central Nervous System ( CNS ) disorder , neuropathy radicular involvement . Acute chronic major psychiatric disorder : schizophrenia , bipolar disorder severe major depressive disorder , severe anxiety disorder except PTSD panic disorder ( PTSD depressive symptom common comorbid condition combat mTBI subset patient symptoms consistent panic disorder well ) . Use illegal drug ; alcohol abuse within past 6 month . Poorly control hypertension , heart failure , coronary heart disease , peripheral artery disease , carotid artery disease , diabetes mellitus , pulmonary disease hypoxia hypercapnia , significant hepatic disease hepatitis C seropositivity , renal failure , treatment cancer , HIV positive , active infectious disease presence abdominal aortic aneurysm . Contraindications lumbar puncture ( LP ) ( e.g. , spinal cord injury ; deformity , severe disease infection region lumbosacral spine ; bleed tendency , use anticoagulant medication , platelet count &lt; 100,000/mm2 ) . Receiving medication investigational drug study . Exclusionary medication ( use 4 week prior screen ) : Fibrates niacin due increase risk myopathy combination statins ; Potential drugdrug interaction statins via effect CYP3A4 : itraconazole , ketoconazole , erythromycin , clarithromycin , HIV protease inhibitor , nefazodone , amiodarone , cyclosporine , isoniazid , quinidine , large quantity grapefruit juice ( &gt; 1 quart daily ) ; Selected CNSacting medication : antipsychotic , antiParkinson 's disease medication CNS stimulants Other medication affect coagulation and/or inflammation : coumadin , potent antiinflammatory medication ( hydrocortisone , methotrexate potent immunemodulating medication ) , antiHIV medication . All female subject childbearing potential undergo urine pregnancy test every subject visit ; subject positive pregnancy test result exclude . In addition , female subject childbearing potential require use reliable method contraception throughout duration study .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>